Financhill
Buy
59

CLX Quote, Financials, Valuation and Earnings

Last price:
$123.49
Seasonality move :
-0.39%
Day range:
$121.81 - $123.61
52-week range:
$96.66 - $159.04
Dividend yield:
4%
P/E ratio:
20.20x
P/S ratio:
2.25x
P/B ratio:
41.96x
Volume:
2.4M
Avg. volume:
2.3M
1-year change:
-19.25%
Market cap:
$14.9B
Revenue:
$7.1B
EPS (TTM):
$6.12

Analysts' Opinion

  • Consensus Rating
    The Clorox Co. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 14 Hold ratings, and 2 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $122.76, The Clorox Co. has an estimated downside of -0.11% from its current price of $123.60.
  • Price Target Upside
    According to analysts, the highest upside price target is $163.00 representing 31.88% upside increase from its current price of $123.60.

Fair Value

  • According to the consensus of 17 analysts, The Clorox Co. has -0.11% downside to fair value with a price target of $122.76 per share.

CLX vs. S&P 500

  • Over the past 5 trading days, The Clorox Co. has underperformed the S&P 500 by -1.89% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • The Clorox Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • The Clorox Co. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter The Clorox Co. reported revenues of $1.7B.

Earnings Growth

  • The Clorox Co. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter The Clorox Co. reported earnings per share of $1.29.
Enterprise value:
18.1B
EV / Invested capital:
--
Price / LTM sales:
2.25x
EV / EBIT:
17.67x
EV / Revenue:
2.68x
PEG ratio (5yr expected):
0.30x
EV / Free cash flow:
23.26x
Price / Operating cash flow:
19.57x
Enterprise value / EBITDA:
14.51x
Gross Profit (TTM):
$3B
Return On Assets:
13.85%
Net Income Margin (TTM):
11.39%
Return On Equity:
398.55%
Return On Invested Capital:
23.77%
Operating Margin:
14.41%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $7.3B $7.2B $6.8B $1.7B $1.7B
Gross Profit $3.1B $3.2B $3B $735M $722M
Operating Income $926M $1.1B $1B $233M $241M
EBITDA $1.2B $1.3B $1.2B $286M $296M
Diluted EPS $0.64 $3.66 $6.12 $1.55 $1.29
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $1.7B $1.6B $1.8B $1.6B $1.7B
Total Assets $6.2B $6B $5.9B $5.6B $5.6B
Current Liabilities $2.6B $1.9B $2B $1.7B $2.3B
Total Liabilities $5.7B $5.6B $5.7B $5.5B $5.6B
Total Equity $491M $491M $218M $121M $35M
Total Debt $2.8B $2.8B $2.8B $2.8B $2.8B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $944M $923M $984M $180M $311M
Cash From Investing -$192M -$84M -$206M -$54M -$43M
Cash From Financing -$542M -$897M -$847M -$109M -$210M
Free Cash Flow $728M $695M $778M $127M $269M
CLX
Sector
Market Cap
$14.9B
$106.9M
Price % of 52-Week High
77.72%
75.17%
Dividend Yield
4%
0%
Shareholder Yield
7.19%
2.16%
1-Year Price Total Return
-19.25%
-1.91%
Beta (5-Year)
0.595
0.244
Dividend yield:
4%
Annualized payout:
$4.88
Payout ratio:
96.29%
Growth streak:
23 years

Technicals

8-day SMA
Sell
Level $123.75
200-day SMA
Buy
Level $118.42
Bollinger Bands (100)
Buy
Level 102.47 - 119.07
Chaikin Money Flow
Buy
Level 11.6M
20-day SMA
Buy
Level $118.17
Relative Strength Index (RSI14)
Buy
Level 67.42
ADX Line
Buy
Level 50.29
Williams %R
Neutral
Level -24.1113
50-day SMA
Buy
Level $109.28
MACD (12, 26)
Buy
Level 28.03
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Neutral
Level 19.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.7591)
Sell
CA Score (Annual)
Level (-1.0641)
Buy
Beneish M-Score (Annual)
Level (-2.4709)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.4723)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Stock Forecast FAQ

In the current month, CLX has received 1 Buy ratings 14 Hold ratings, and 2 Sell ratings. The CLX average analyst price target in the past 3 months is $122.76.

  • Where Will The Clorox Co. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that The Clorox Co. share price will drop to $122.76 per share over the next 12 months.

  • What Do Analysts Say About The Clorox Co.?

    Analysts are divided on their view about The Clorox Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that The Clorox Co. is a Buy and believe this share price will rise from its current level to $163.00.

  • What Is The Clorox Co.'s Price Target?

    The price target for The Clorox Co. over the next 1-year time period is forecast to be $122.76 according to 17 Wall Street analysts, 1 of them rates the stock a Buy, 2 rate the stock a Sell, and 14 analysts rate the stock a Hold.

  • Is CLX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for The Clorox Co. is a Hold. 14 of 17 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CLX?

    You can purchase shares of The Clorox Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Clorox Co. shares.

  • What Is The The Clorox Co. Share Price Today?

    The Clorox Co. was last trading at $123.49 per share. This represents the most recent stock quote for The Clorox Co.. Yesterday, The Clorox Co. closed at $123.60 per share.

  • How To Buy The Clorox Co. Stock Online?

    In order to purchase The Clorox Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock